Oxcarbazepine Suspension
Product Images NDC 68999-841

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68999-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Governmental & Specialty Rx, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Graph 1)

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Graph 2)

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Graph 3)

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Graph 4)

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Structure)

FDA Label Image

Oxcarbazepine Oral Suspension, Usp 300 mg/5 mL (NDC 68999-841-45)

Oxcarbazepine Oral Suspension, Usp 300 mg/5 mL (NDC 68999-841-45)
This is a description of OXCARBAZEPINE oral suspension, USP, with a strength of 300mg per 5 mL. The medication is packaged with an NDC number 68999-841-45. It is advised to shake well before using. This product is intended for institutional use only and is prescription-only. The manufacturer is stated as Chartwell Governmental & Specialty RX, LLC located in Congers, NY. A lot number is provided as 000000.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.